130 related articles for article (PubMed ID: 2192004)
1. The ability of recombinant murine granulocyte-macrophage colony-stimulating factor to protect neonatal rats from septic death due to Staphylococcus aureus.
Frenck RW; Sarman G; Harper TE; Buescher ES
J Infect Dis; 1990 Jul; 162(1):109-14. PubMed ID: 2192004
[TBL] [Abstract][Full Text] [Related]
2. Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3.
Cairo MS; Mauss D; Plunkett JM; Gillis S; van de Ven C
Pediatr Res; 1991 May; 29(5):504-9. PubMed ID: 1896256
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of recombinant murine granulocyte-macrophage colony-stimulating factor against Pseudomonas aeruginosa infection in leukocytopenic mice.
Tanaka T; Okamura S; Okada K; Suga A; Shimono N; Ohhara N; Hirota Y; Sawae Y; Niho Y
Infect Immun; 1989 Jun; 57(6):1792-9. PubMed ID: 2656523
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.
Morstyn G; Lieschke GJ; Sheridan W; Layton J; Cebon J; Fox RM
Semin Hematol; 1989 Apr; 26(2 Suppl 2):9-13. PubMed ID: 2471275
[TBL] [Abstract][Full Text] [Related]
5. Recombinant murine granulocyte-macrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infections in myelosuppressed mice.
Mayer P; Schütze E; Lam C; Kricek F; Liehl E
J Infect Dis; 1991 Mar; 163(3):584-90. PubMed ID: 1995731
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats.
Cairo MS; Mauss D; Kommareddy S; Norris K; van de Ven C; Modanlou H
Pediatr Res; 1990 Jun; 27(6):612-6. PubMed ID: 1694023
[TBL] [Abstract][Full Text] [Related]
7. Action of granulopoiesis-stimulating cytokines rhG-CSF, rhGM-CSF, and rmGM-CSF on murine haematopoietic progenitor cells for granulocytes and macrophages (GM-CFC).
Hofer M; Vacek A; Weiterová L
Physiol Res; 2005; 54(2):207-13. PubMed ID: 15544422
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients.
Baldwin GC; Gasson JC; Quan SG; Fleischmann J; Weisbart R; Oette D; Mitsuyasu RT; Golde DW
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2763-6. PubMed ID: 3282238
[TBL] [Abstract][Full Text] [Related]
9. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
Iguchi K; Inoue S; Kumar A
Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
[TBL] [Abstract][Full Text] [Related]
11. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
Neta R; Oppenheim JJ; Douches SD
J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic growth factors: biology and clinical application.
Gabrilove JL; Jakubowski A
J Natl Cancer Inst Monogr; 1990; (10):73-7. PubMed ID: 1693284
[TBL] [Abstract][Full Text] [Related]
13. The promise of colony-stimulating factors in clinical practice.
Glaspy JA; Ambersley JM
Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043
[TBL] [Abstract][Full Text] [Related]
14. Agranulocytosis associated with T-gamma-lymphocytosis: no improvement of peripheral blood granulocyte count with human-recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF).
Thomssen C; Nissen C; Gratwohl A; Tichelli A; Stern A
Br J Haematol; 1989 Jan; 71(1):157-8. PubMed ID: 2644967
[No Abstract] [Full Text] [Related]
15. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs.
Mayer P; Werner FJ; Lam C; Besemer J
Exp Hematol; 1990 Oct; 18(9):1026-33. PubMed ID: 2168838
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance.
Gennari R; Alexander JW; Gianotti L; Eaves-Pyles T; Hartmann S
Ann Surg; 1994 Jul; 220(1):68-76. PubMed ID: 8024361
[TBL] [Abstract][Full Text] [Related]
17. Modulation of neonatal rat myeloid kinetics resulting in peripheral neutrophilia by single pulse administration of Rh granulocyte-macrophage colony-stimulating factor and Rh granulocyte colony-stimulating factor.
Cairo MS; van de Ven C; Mauss D; Kommareddy S; Norris K; Sheikh K; Modanlou H
Biol Neonate; 1991; 59(1):13-21. PubMed ID: 1707685
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: a phase Ib trial.
Steis RG; VanderMolen LA; Longo DL; Clark JW; Smith JW; Kopp WC; Ruscetti FW; Creekmore SP; Elwood LJ; Hursey J
J Natl Cancer Inst; 1990 Apr; 82(8):697-703. PubMed ID: 2138680
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte macrophage colony stimulating factor (GM-CSF) current status and future development.
Bonnem EM; Morstyn G
Semin Oncol; 1988 Oct; 15(5 Suppl 5):46-51. PubMed ID: 3057644
[No Abstract] [Full Text] [Related]
20. Review of G-CSF and GM-CSF. Effects on neonatal neutrophil kinetics.
Cairo MS
Am J Pediatr Hematol Oncol; 1989; 11(2):238-44. PubMed ID: 2473663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
